May 17 |
Pulse Biosciences names new CEO, reassigns former leader
|
May 16 |
Pulse Biosciences Stock: Signs Of Life Following Q1 Update
|
May 16 |
Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
|
May 14 |
Pulse Biosciences appoints Burke Barrett as CEO
|
May 14 |
Pulse Biosciences Enhances Executive Leadership Team
|
May 13 |
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call Transcript
|
May 11 |
Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript
|
May 11 |
Pulse Biosciences Insiders Added US$9.69m Of Stock To Their Holdings
|
May 9 |
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
|
May 8 |
Q1 2024 Pulse Biosciences Inc Earnings Call
|